Operating Income: The income after operating expenses.
AC Immune (ACIU) had Operating Income of $-23.50M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.58M |
|
$-25.69M |
|
-- |
|
$1.58M |
|
$25.09M |
|
|
Operating Income |
$-23.50M |
$-2.18M |
|
$-25.69M |
|
$-25.69M |
|
$-25.69M |
|
$-25.69M |
|
$-25.69M |
|
$-25.69M |
|
$-23.50M |
|
$-22.69M |
|
100.63M |
|
100.63M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$159.78M |
|
$3.02M |
|
$70.81M |
|
$230.59M |
|
$119.97M |
|
-- |
|
$20.02M |
|
$139.99M |
|
$90.60M |
|
$29.49M |
|
$90.60M |
|
-- |
|
| Cash Flow Statement Financials | |
$-41.72M |
|
$32.62M |
|
$-0.61M |
|
$43.97M |
|
$31.18M |
|
$-12.79M |
|
$3.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1484.53% |
|
-1484.53% |
|
-- |
|
-1622.43% |
|
-1622.43% |
|
$-42.59M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.81 |
|
111.71 |
|
-28.35% |
|
-87.10% |
|
-11.14% |
|
-28.35% |
|
-- |
|
$-0.42 |
|
$-0.41 |
|